Medical and Pharmaceutical Freenome gets FDA breakthrough designation for ‘SimpleScreen’ lung cancer blood test Achievement builds on firm securing agency's approval for a colorectal cancer test variation Rowan DunneAugust 13, 2026
Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
Medical and Pharmaceutical Roche collaboration to accelerate Freenome’s blood-based cancer screening The companies intend to work jointly on improving Freenome’s cell-free DNA cancer tests Joseph MortonNovember 25, 2025
Medical and Pharmaceutical Australian biotech uncovers broader view of tumour genetics with liquid biopsy The team developed the study in collaboration with US sequencing company Illumina Joseph MortonJune 17, 2025